Thomas Robert
Thomas Robert is an expert in Nephrology at Hôpitaux universitaires de Marseille (France). Thomas Robert has authored 232 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 3 of them ongoing. SLR score: 923 (community average: 125). How the SLR is computed.
LeadR Profile
Nephrology
Subspecialties: Transplantation - Biochemistry - Urology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2006 - 2026
Number : 232
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Chromatin remodeling coordinates chromosome compaction, synaptonemal complex architecture and meiotic crossing-over. PMID 42818913 — synaptonemal complex, crossing over, genetic, recombination, genetic, chromatin, nucleosomes, environment, chromosomes, meiosis | Res Sq | 2026 | 0 |
| From monogenic screening to polygenic risk: the future of donor safety. PMID 42760009 — kidney diseases, safety, kidney | Kidney Int | 2026 | 0 |
| Real-time, Multidisciplinary Approach of Women With Pregnancy-Associated Thrombotic Microangiopathy. PMID 42502667 — thrombotic microangiopathies, pregnancy, pre-eclampsia, therapeutics, postpartum period, acute kidney injury | Kidney Int Rep | 2026 | 0 |
| Primary hyperoxaluria type 1-current practice in the siRNA era: an ERA Genes & Kidney Working Group survey. PMID 42395860 — genes, rna, small interfering, hyperoxaluria, primary, hyperoxaluria, kidney, therapeutics, oxalates, nephrolithiasis, nephrocalcinosis | Clin Kidney J | 2026 | 1 |
| Cholecalciferol and muscle strength in hemodialysis patients: results from the randomized VITADIAL trial. PMID 42389197 — muscles, vitamins, muscle strength, cholecalciferol | Clin Kidney J | 2026 | 0 |
Clinical Studies 7
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 4
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study NCT06350630 — proteinuria, pharmaceutical preparations, tablets, immunoglobulins, immunoglobulin a, immunity, mucosal, hydroxychloroquine, immunity, therapeutics, glomerulonephritis, iga, glomerulonephritis | Phase 2 | Recruiting | 2025 |
| Heparin Free Chronic HemoDialysis Assessment NCT06224140 — anticoagulants, hemorrhage, blood, baths, heparin, kidney, solutions, calcium, kidney failure, chronic, therapeutics, blood platelets, heparin, low-molecular-weight | N/A | Not yet recruiting | 2024 |
| Efficacy and Tolerance of RHEOpheresis in the Treatment of Peripheral Artery Disease in Hemodialysis Patients NCT03975946 — macular degeneration, microcirculation, blood, pathology, amputation, surgical, arteries, kidney failure, chronic, peripheral arterial disease, therapeutics, plasma | N/A | Recruiting | 2021 |
LeadR Networks
Main global connection map